ASHLEY
Fractional RF Micro-needle
ASHLEY is a groundbreaking fractional radiofrequency micro-needle device, innovatively designed to overcome the drawbacks associated with traditional lasers that can potentially damage the skin surface as they invariably penetrate through it.
​
Differentiating itself, ASHLEY employs insulated micro-needles that penetrate the dermis directly, delivering optimal high-frequency energy without damaging the skin surface.
​
This process forms coagulated columns, fostering healing and generating ample collagen layers. The RF capability ensures a controlled energy delivery per shot ensuring consistent ideal clinical results.
No or minimized skin surface damage
The drawback associated with traditional lasers is that they can potentially damage the skin surface as they invariably penetrate through it.
On the other hand, ASHLEY often employs insulated micro-needles that penetrate the dermis directly, delivering optimal high-frequency energy without damaging the skin surface.
Controllable depth from 0.5 to 4.0 mm
The physician can adjust the penetration depth of the needle tip based on the targeted depth within the skin. Through manipulation of the device settings in the user interface, the needles depth can range from 0.5 to 4.0 mm beneath the skin surface.
Technology and skin reaction
In a fractional RF microneedle system, the choice between insulated and non-insulated needles plays a crucial role in determining the impact on skin damage and tissue coagulation. Choosing between insulated and non-insulated needles depends on the treatment goals.
Insulated needles are often preferred when the focus is on minimizing surface damage and precisely controlling the depth of penetration for specific skin concerns.
Non-insulated needles may be chosen for treatments where a more widespread impact and coagulation are desired, even at the expense of some superficial damage.
Only 1 to 2 days of minimal downtime
The skin surface damage when treated with ASHLEY is minimized as the insulated micro-needles penetrate the dermis directly. This results in a minimal downtime of only 1 to 2 days after the treatment, allowing patients to swiftly resume their normal activities.
Tips for different clinical goals
No or minimized skin surface damage
Indication
Technical specification
